Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
University of UtahRecruitingBreast Cancer | Breast ReconstructionUnited States
-
University of California, San FranciscoAmgenCompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Veana TherapeuticsUniversity of WashingtonSuspendedAnatomic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); AmgenActive, not recruitingEdema | Erythema | Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Inflammatory Breast Carcinoma | Breast Lump | Peau d'OrangeUnited States
-
Virginia G. KaklamaniWithdrawnTriple Negative Breast Cancer | DNA Damage Repair DeficiencyUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Stemline Therapeutics, Inc.CompletedAdvanced ER+, HER2-Negative Breast CancerUnited States
-
University of ArizonaCompletedEstrogen Levels Among Breast Cancer PatientsUnited States
-
Mount Mary UniversityCompletedBreast Cancer Female | SurvivorshipUnited States
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
St. Joseph's Hospital, FloridaTerminatedBreast Cancer Metastatic to the LiverUnited States
-
Rutgers, The State University of New JerseyRegeneron PharmaceuticalsRecruitingBreast Cancer | Breast Cancer Risk | Breast Cancer PreventionUnited States
-
Washington University School of MedicineBiovicaRecruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Washington University School of MedicineUnited States Department of Defense; Rising Tide FoundationActive, not recruitingBreast Cancer | Breast Carcinoma | Malignant Neoplasm of BreastUnited States
-
Stephen ShiaoUnited States Department of DefenseActive, not recruiting
-
University of RochesterWithdrawnHER2-positive Breast CancerUnited States
-
New Mexico Cancer Research AllianceActive, not recruitingHER2 Negative Breast CancerUnited States
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted
-
University of ArkansasUnited States Department of DefenseCompleted
-
Dartmouth-Hitchcock Medical CenterTerminatedLocally Advanced Breast CancerUnited States
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Yale UniversityBristol-Myers SquibbRecruiting
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid NeoplasmUnited States
-
University of WashingtonNational Cancer Institute (NCI); University of Wisconsin, MadisonCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | No Evidence of Disease | One or More Positive Axillary NodesUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Vermont Medical CenterNot yet recruitingBreast Cancer | HER-2 Positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteBreast Cancer Research FoundationRecruitingBreast Cancer | Breast Cancer FemaleUnited States
-
University of FloridaRecruiting
-
University of LouisvilleJames Graham Brown Cancer CenterRecruitingMetastatic Breast CancerUnited States
-
Minerva Biotechnologies CorporationCity of Hope Medical CenterRecruitingMetastatic Breast CancerUnited States
-
University of Wisconsin, MadisonNational Center for Advancing Translational Sciences (NCATS)CompletedInvasive Breast CancerUnited States
-
EirGenix, Inc.Withdrawn
-
University of Central FloridaCompleted
-
University of Illinois at ChicagoActive, not recruiting
-
Colin Champ, MDCompletedBreast Cancer FemaleUnited States
-
Sentara Norfolk General HospitalActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast CarcinomaUnited States
-
Rush University Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
University of Maryland, BaltimoreGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedMETASTATIC BREAST CANCERUnited States
-
Baylor Research InstituteCompletedMetastatic Breast CancerUnited States
-
Fox Chase Cancer CenterAmerican Cancer Society, Inc.CompletedBreast Cancer FemaleUnited States
-
Columbia UniversityAvon FoundationCompletedInvasive Breast CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
University of Wisconsin, MadisonAmgenCompleted